Birchview Capital, LP
72 holdingsFiling period: 2026-06-30Current AUM: $180.3Mestimated from latest prices
| # | Ticker | Company | Shares | Reported Value | Current Value | % Portfolio | Change | Date |
|---|---|---|---|---|---|---|---|---|
| 1 | KLAC | KLA CORPORATION | 178.5K | $53.8M | $30.0M | 16.63% | +158.6K | 2026-06-30 |
| 2 | BMY | BRISTOL-MYERS SQUIBB CO | 297.2K | $17.1M | $18.9M | 10.50% | -9,025 | 2026-06-30 |
| 3 | LRCX | LAM RESEARCH CORPORATION | 35.0K | $15.2M | $9.5M | 5.26% | -1,000 | 2026-06-30 |
| 4 | NTLA | INTELLIA THERAPEUTICS INC | 385.9K | $6.8M | $4.6M | 2.52% | -59,500 | 2026-06-30 |
| 5 | SLDB | SOLID BIOSCIENCES INC | 666.2K | $6.7M | $5.6M | 3.09% | +40.2K | 2026-06-30 |
| 6 | BDSX | BIODESIX INC | 286.8K | $6.5M | $7.9M | 4.40% | -- | 2026-06-30 |
| 7 | STOK | STOKE THERAPEUTICS INC | 178.1K | $5.8M | $5.0M | 2.78% | -31,890 | 2026-06-30 |
| 8 | OVV | OVINTIV INC | 107.5K | $5.7M | $7.2M | 3.99% | -- | 2026-06-30 |
| 9 | NKTR | NEKTAR THERAPEUTICS | 81.0K | $5.7M | $5.4M | 2.99% | +50.0K | 2026-06-30 |
| 10 | CORT | CORCEPT THERAPEUTICS INC | 57.2K | $5.0M | $6.3M | 3.51% | +10.0K | 2026-06-30 |
| 11 | NBIX | NEUROCRINE BIOSCIENCES INC | 27.2K | $4.6M | $4.1M | 2.26% | -- | 2026-06-30 |
| 12 | — | PROTHENA CORP PLC | 449.0K | $4.4M | $4.4M | 2.44% | -- | 2026-06-30 |
| 13 | ACAD | ACADIA PHARMACEUTICALS INC | 171.0K | $4.3M | $4.6M | 2.54% | -- | 2026-06-30 |
| 14 | PTGX | PROTAGONIST THERAPEUTICS INC | 35.0K | $4.3M | $5.0M | 2.78% | +18 | 2026-06-30 |
| 15 | CMPX | COMPASS THERAPEUTICS INC | 1.68M | $3.7M | $3.1M | 1.72% | +209.1K | 2026-06-30 |
| 16 | RLMD | RELMADA THERAPEUTICS INC | 408.1K | $2.8M | $1.8M | 1.00% | -1,287 | 2026-06-30 |
| 17 | — | ALKERMES PLC | 50.0K | $2.6M | $2.6M | 1.45% | -- | 2026-06-30 |
| 18 | HALO | HALOZYME THERAPEUTICS INC | 33.3K | $2.6M | $3.5M | 1.96% | +23.2K | 2026-06-30 |
| 19 | CLDX | CELLDEX THERAPEUTICS INC | 69.9K | $2.6M | $2.7M | 1.49% | -195 | 2026-06-30 |
| 20 | CYTK | CYTOKINETICS INC | 30.0K | $2.6M | $2.1M | 1.15% | -- | 2026-06-30 |
| 21 | OLMA | OLEMA PHARMACEUTICALS INC | 199.0K | $2.5M | $1.9M | 1.08% | -20,000 | 2026-06-30 |
| 22 | VERA | VERA THERAPEUTICS INC | 57.8K | $2.5M | $1.9M | 1.08% | +13.8K | 2026-06-30 |
| 23 | UTHR | UNITED THERAPEUTICS CORP | 4.5K | $2.4M | $2.3M | 1.25% | +6 | 2026-06-30 |
| 24 | ZBIO | ZENAS BIOPHARMA INC | 93.6K | $2.4M | $3.0M | 1.66% | +23.6K | 2026-06-30 |
| 25 | — | UNIQURE NV | 50.7K | $2.3M | $2.3M | 1.29% | -50,000 | 2026-06-30 |
← Scroll →
Page 1 of 3